cetpinhibition.org

Genetics

Review details CETP's LBP-gene-family membership and the molecular basis of CETP-deficiency hyperalphalipoproteinemia (Biochim Biophys Acta 2000)

Original title: Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein

Biochim Biophys Acta · · 6

Yamashita S, Hirano K, Sakai N, Matsuzawa Y

This review covers CETP's role transferring cholesteryl ester from HDL to apoB-containing lipoproteins in reverse cholesterol transport, and its membership, along with phospholipid transfer protein, in the lipid transfer/lipopolysaccharide-binding protein gene family, which also includes LBP and bactericidal/permeability-increasing protein, sharing biochemical and structural similarities despite differing functions. It details CETP-deficient hyperalphalipoproteinemia (HALP), caused in Japanese patients mainly by two mutations, an intron 14 splicing defect and the D442G exon 15 missense mutation, which alter HDL and LDL concentration, composition, and function; in vitro work shows the resulting large, CE-rich HDL is defective in cholesterol efflux. Epidemiological studies in Japanese-Americans and Japan's Omagari area, where the intron 14 defect is common, found increased coronary atherosclerosis in CETP-deficient subjects, despite the continuing controversy over CETP's overall pathophysiological role.

Read the paper (DOI)PubMed

Original abstract

Plasma cholesteryl ester transfer protein (CETP) facilitates the transfer of cholesteryl ester (CE) from high density lipoprotein (HDL) to apolipoprotein B-containing lipoproteins. Since CETP regulates the plasma levels of HDL cholesterol and the size of HDL particles, CETP is considered to be a key protein in reverse cholesterol transport, a protective system against atherosclerosis. CETP, as well as plasma phospholipid transfer protein, belongs to members of the lipid transfer/lipopolysaccharide-binding protein (LBP) gene family, which also includes the lipopolysaccharide-binding protein (LBP) and bactericidal/permeability-increasing protein. Although these four proteins possess different physiological functions, they share marked biochemical and structural similarities. The importance of plasma CETP in lipoprotein metabolism was demonstrated by the discovery of CETP-deficient subjects with a marked hyperalphalipoproteinemia (HALP). Two common mutations in the CETP gene, intron 14 splicing defect and exon 15 missense mutation (D442G), have been identified in Japanese HALP patients with CETP deficiency. The deficiency of CETP causes various abnormalities in the concentration, composition, and functions of both HDL and low density lipoprotein. Although the pathophysiological significance of CETP in terms of atherosclerosis has been controversial, the in vitro experiments showed that large CE-rich HDL particles in CETP deficiency are defective in cholesterol efflux. Epidemiological studies in Japanese-Americans and in the Omagari area where HALP subjects with the intron 14 splicing defect of CETP gene are markedly frequent, have shown an increased incidence of coronary atherosclerosis in CETP-deficient patients. The current review will focus on the recent findings on the molecular biology and pathophysiological aspects of plasma CETP, a key protein in reverse cholesterol transport.

geneticsHDL biologymechanisms

Summary written by cetpinhibition.org from the published abstract; figures as published. Page updated 19 August 2026. Methods.